• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

anti-KRT7 antibody product blog

Tags: Antibody; Polyclonal Antibody; anti-KRT7 antibody; KRT7;

     The KRT7 krt7 (Catalog #MBS9210882) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The KRT7 Antibody (N-term) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s KRT7 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC).
WB~~1:1000. Researchers should empirically determine the suitability of the KRT7 krt7 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The KRT7 krt7 product has the following accession number(s) (GI #67782365) (NCBI Accession #NP_005547.3) (Uniprot Accession #P08729). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:


Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the KRT7 Antibody (N-term) with the following immunoassay(s):
Western Blot (WB) (KRT7 Antibody (N-term) western blot analysis in A549 cell line lysates (35ug/lane).This demonstrates the KRT7 antibody detected the KRT7 protein (arrow).)
Western Blot (WB) KRT7.

Immunohistochemistry (IHC) (KRT7 Antibody (N-term) (MBS9210882)immunohistochemistry analysis in formalin fixed and paraffin embedded human bladder carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of KRT7 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.)
Immunohistochemistry (IHC) KRT7.

The protein encoded by this gene is a member of the
keratin gene family. The type II cytokeratins consist of basic or
neutral proteins which are arranged in pairs of heterotypic keratin
chains coexpressed during differentiation of simple and stratified
epithelial tissues. This type II cytokeratin is specifically
expressed in the simple epithelia lining the cavities of the
internal organs and in the gland ducts and blood vessels. The genes
encoding the type II cytokeratins are clustered in a region of
chromosome 12q12-q13. Alternative splicing may result in several
transcript variants; however, not all variants have been fully
described.

Antigen Type: Synthetic Peptide. Antigen Source: HUMAN. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing KRT7 are readily searchable from our website. Different antibodies against the same target such as KRT7 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Bladder, Intestine, Kidney, Liver, Lung, Ovary, Placenta, Skin, Stomach, Thyroid tissues are correlated with this protein. Adenocarcinoma, Breast Neoplasms, Kidney Diseases, Liver Diseases, Liver Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Ovarian Diseases, Skin Diseases are some of the diseases may be linked to KRT7 Antibody (N-term).
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
1146 - Table 'mbsds_xtra.countries' doesn't exist

select countries_id, countries_name from countries order by countries_name

[TEP STOP]